GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. - Wikidata - wikimedia - TriplyDB

GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.

GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.

http://www.wikidata.org/entity/Q34471118

about

Role of Glia in Memory Deficits Following Traumatic Brain Injury: Biomarkers of Glia Dysfunction Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease Blood biomarkers for brain injury: What are we measuring?Functional, Structural, and Neurotoxicity Biomarkers in Integrative Assessment of Concussions.Potential Blood-based Biomarkers for Concussion.Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases.Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion.Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light Performance of Glial Fibrillary Acidic Protein in Detecting Traumatic Intracranial Lesions on Computed Tomography in Children and Youth With Mild Head Trauma A blood-based biomarker panel to risk-stratify mild traumatic brain injury.H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.Current status of fluid biomarkers in mild traumatic brain injury In Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.Behavioral, blood, and magnetic resonance imaging biomarkers of experimental mild traumatic brain injury.Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury.Brain Monitoring in Critically Neurologically Impaired Patients.Clinical features and biomarkers of concussion and mild traumatic brain injury in pediatric patients.Prospective Assessment of Acute Blood Markers of Brain Injury in Sport-Related Concussion.Biomarkers of Traumatic Brain Injury: Temporal Changes in Body Fluids Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries.A Panel of Serum MiRNA Biomarkers for the Diagnosis of Severe to Mild Traumatic Brain Injury in Humans.Metabolomics Profiling As a Diagnostic Tool in Severe Traumatic Brain Injury.Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury.Emergency Department Evaluation of Traumatic Brain Injury in the United States, 2009-2010.A Systematic Review of the Usefulness of Glial Fibrillary Acidic Protein for Predicting Acute Intracranial Lesions following Head Trauma.A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury.The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.Biofluid biomarkers of traumatic brain injury.Can Astrocytes Be a Target for Precision Medicine?Raising the Bar for Traumatic Brain Injury Biomarker Research: Methods Make a Difference.Why have we not yet developed a simple blood test for TBI?Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.Elevated Serum Glial Fibrillary Acidic Protein (GFAP) is Associated with Poor Functional Outcome After Cardiopulmonary Resuscitation.Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury?Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury.Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.MicroRNA Signature of Traumatic Brain Injury: From the Biomarker Discovery to the Point-of-Care.Biomarkers for acute diagnosis and management of stroke in neurointensive care units

P2860

Q26766026-46DD69EC-FE79-4387-9892-589BB6CBFB0D Q27027066-C633D6B6-39A3-4B76-9E9B-D9A82C653EF5 Q28067275-9D25ED18-99F7-4CEF-A4BB-7A7360580E4B Q30372117-C2DFEBA9-ACBB-492F-8A20-47410AF504A8 Q31119100-FF8B37D6-A8EE-467E-A67A-5D82B1422438 Q33891870-2FC309F4-6BE8-4640-A0B6-57E88959F48D Q35589772-1FBE0EF2-EDD1-4D40-B68A-85505678E6F6 Q35681358-BA786FEC-91C7-4CAD-A53C-68D9D9981E12 Q36264759-D5BF3441-7757-4A36-9222-AB1AE935A4DB Q36326665-A4848B88-E4C3-453C-92F7-43B54DC76935 Q36349690-87647D7A-B1EF-4A69-AA89-D201AB0EAC83 Q36424343-0C5E4C34-FEB9-45B0-B806-9BB057F8E44D Q36427671-824FEEA8-6EB7-4720-9E74-03992BC0F5E2 Q36489525-54E9DF5A-4BD1-4F8D-989D-6E82EE1B421D Q37044518-CFDBD633-E43A-43DF-832A-50C914A2501D Q37240562-AA6B7095-6437-480E-9597-1E7DD8035AB2 Q37590627-BB1CC552-4F27-403B-AC0E-3328834120EC Q37631441-86036615-5865-4286-98BC-1FA714290316 Q38391218-E198ABDA-10A3-4216-955E-77FFB47BAF14 Q38658776-9BF776D6-5B7C-48C7-9364-E6BF800BF0FB Q39061827-7466C2F6-51F7-4430-B653-8E522FAFCE09 Q39257016-88634444-212A-42BF-8609-C2AAB0FD482B Q39659098-734518FB-6C1E-4C24-B406-5EFCA84311EB Q41462915-E2B800B5-EEE2-41EE-B0EB-B3C0CC4885F1 Q42264480-5B376FDC-0BCB-4493-ACCA-C976749EEDD2 Q42685951-A08DE156-5D1B-4877-B407-7AC2C7917D4D Q47098470-4FB3D146-837A-4C21-B29F-3737060FC05B Q47250022-43BEAE93-44B9-4448-8A64-1ED70439F158 Q47579460-C659E97C-7E12-4E37-A832-6F1E9999DEA9 Q47605675-656E171D-5D7F-4F41-965C-434D897F611D Q48140499-31A25E1A-AB80-4C3E-9A3F-EC91DD1E242F Q48254547-1FEFDABC-D11C-4920-A90C-F79566B2FE6C Q48256272-CCABEBD6-0DD7-4D73-9E84-D79901A67E3A Q48320047-82EDDAC4-EB44-4179-A983-705C6E69DD94 Q48372086-75EE7CD5-ADA0-4FC4-BC2C-775E785151CE Q48623917-A20EEB58-D558-4404-916C-483DC2B6438F Q50333243-690B6EFF-8D93-4A75-8F1A-B8439497A91F Q52147346-61EB2835-8DBC-495F-8B58-6E1D6DC2C5CF Q55432318-B6E054DC-F78F-43C8-8413-100F71C43ACA Q57764731-D07EB325-58C6-4900-945A-89731E534E88

P2860

GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.

http://www.wikidata.org/entity/Q34471118

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

GFAP out-performs S100β in det ...... ose with extracranial lesions.

@ast

GFAP out-performs S100β in det ...... ose with extracranial lesions.

@en

GFAP out-performs S100β in det ...... ose with extracranial lesions.

@nl

type

label

GFAP out-performs S100β in det ...... ose with extracranial lesions.

@ast

GFAP out-performs S100β in det ...... ose with extracranial lesions.

@en

GFAP out-performs S100β in det ...... ose with extracranial lesions.

@nl

prefLabel

GFAP out-performs S100β in det ...... ose with extracranial lesions.

@ast

GFAP out-performs S100β in det ...... ose with extracranial lesions.

@en

GFAP out-performs S100β in det ...... ose with extracranial lesions.

@nl

P1433

Q34471118-2A764F43-434E-4F8C-B68F-11C3401F0B26

P1476

Q34471118-EC588631-14CA-4342-8379-AD186791EFB3

P2093

Q34471118-11A815A2-CC63-411C-ADDB-F7795F5D127C

Q34471118-3E5D6E98-7D20-43CF-8F05-0A19922B65B1

Q34471118-5FC13949-1C55-4F13-96BA-950BE051CBF3

Q34471118-6369B867-105F-4AC5-B0EB-9172182C00A7

Q34471118-63F47314-725F-4DF1-82E7-13F8DF453832

Q34471118-6B590265-E51F-420D-8011-C1772FF91C32

Q34471118-7AF56999-D02C-42B5-BD49-9179E743F49A

Q34471118-887C71A2-5A67-426B-B992-970B497BB222

Q34471118-A1929613-D461-4759-A6DE-B5F7C8234A89

Q34471118-CFED27D1-2A3C-4A59-A2B6-44D54533BFF5

P2860

Q34471118-2425709B-C132-422D-A8EA-9CF0646454C9

Q34471118-299A53F6-8800-487B-AEF1-78738E57D22B

Q34471118-2BB7512F-C814-4A80-80D7-B13A9A35649F

Q34471118-2D3C8DF8-7C33-4AAB-BD8B-38BA60B6DF40

Q34471118-33C16760-2ADF-4749-B51C-F993EB1874F9

Q34471118-35CF51AD-F9FB-4637-AC8B-8628C41B7566

Q34471118-39FC417A-C0C5-4900-9CA3-9A74D1C69F80

Q34471118-3DE172F8-8F7B-46BF-8456-45B8A9FE68E1

Q34471118-3F02B63A-D3F4-4574-9524-CF7BB3169684

Q34471118-48002A8F-2CBC-4CF5-84E8-98B8C965C7A3

P304

Q34471118-692BE8A2-B6EF-496F-ADE4-0EB956346F1B

P31

Q34471118-4E3C662F-7B4A-4D2B-BF6A-326D45BA5625

P356

Q34471118-59488A87-E8B8-4AAF-B21B-098EDF6C2960

P433

Q34471118-231D5D11-0DE9-47C3-9043-0184B7AA90C0

P478

Q34471118-D23C014B-1A3D-4DA3-86BE-1690B1BAB292

P50

Q34471118-455118A7-89DC-4D3B-8045-32A505448437

Q34471118-A52E62CB-F1F4-4C09-A34D-3002402AD4DB

P577

Q34471118-40F1DA05-AF14-4260-BFCB-4DC4CEE00491

P5875

Q34471118-B1AEB502-8710-424A-925C-5B1E58F767A1

P698

Q34471118-1AFE76C4-5ABC-4B9C-B1A3-BF34E4430719

P921

Q34471118-6A821829-DB48-4F1E-A102-7ADFD63B49E6

P932

Q34471118-E452D706-746A-426E-961B-73ADE8DDBCAD

P356

P1433

Journal of Neurotrauma

P1476

GFAP out-performs S100β in det ...... ose with extracranial lesions.

@en

P2093

Carolina F Braga

http://www.w3.org/2001/XMLSchema#string

Ciara N Tan

http://www.w3.org/2001/XMLSchema#string

Claudia S Robertson

http://www.w3.org/2001/XMLSchema#string

Jason A Demery

http://www.w3.org/2001/XMLSchema#string

Jay L Falk

http://www.w3.org/2001/XMLSchema#string

Linda Papa

http://www.w3.org/2001/XMLSchema#string

Matthew E Mendes

http://www.w3.org/2001/XMLSchema#string

Neema J Ameli

http://www.w3.org/2001/XMLSchema#string

Neha K Dixit

http://www.w3.org/2001/XMLSchema#string

Philip Giordano

http://www.w3.org/2001/XMLSchema#string

P2860

The S100 protein family: history, function, and expression

Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: a prospective multicenter study.

Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.

Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making.

Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.

Biomarker-based dissection of neurodegenerative diseases.

Systematic review of clinical research on biomarkers for pediatric traumatic brain injury.

Relationship of serum S100B levels and intracranial injury in children with closed head trauma.

GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study.

GFAP and S100B in the acute phase of mild traumatic brain injury.

P304

1815-1822

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/NEU.2013.3245

http://www.w3.org/2001/XMLSchema#string

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Gretchen Brophy

P577

2014-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262942631

http://www.w3.org/2001/XMLSchema#string

P698

24903744

http://www.w3.org/2001/XMLSchema#string

P921

traumatic brain injury

P932

4224051

http://www.w3.org/2001/XMLSchema#string